Author

Chengyu Wang

Observed name: Cheng-Yu Wang

Institution: Guangzhou Medical University

Observed institutions: Second Affiliated Hospital of Guangzhou Medical University, Guangzhou Medical University

ORCID: 0000-0003-0516-332X

Observed ORCID: 0000-0003-0516-332X

OpenAlex ID: A5015658461

Rapid and longer-term antidepressant effects of repeated-dose intravenous ketamine for patients with unipolar and bipolar depression

2018 · Wei Zheng, Yan-Ling Zhou, et al. · Journal of Psychiatric Research · 178

Neurocognitive performance and repeated-dose intravenous ketamine in major depressive disorder

2018 · Wei Zheng, Yan-Ling Zhou, et al. · Journal of Affective Disorders · 64

Cross-sectional relationship between kynurenine pathway metabolites and cognitive function in major depressive disorder

2018 · Yanling Zhou, Wei Zheng, et al. · Psychoneuroendocrinology · 57

Effect of Repeated Intravenous Esketamine on Adolescents With Major Depressive Disorder and Suicidal Ideation: A Randomized Active-Placebo-Controlled Trial

2023 · Yanling Zhou, Xiaofeng Lan, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 55

Mediating effect of neurocognition between severity of symptoms and social-occupational function in anxious depression

2018 · Weijian Liu, Yanling Zhou, et al. · Journal of Affective Disorders · 14

Non-improvement predicts subsequent non-response to repeated-dose intravenous ketamine for depression: a re-analysis of a 2-week open-label study in patients with unipolar and bipolar depression

2024 · Chengyu Wang, Xiaofeng Lan, et al. · Translational Psychiatry · 8

Functional connectivity of the amygdala subregions and the antidepressant effects of repeated ketamine infusions in major depressive disorder

2024 · Haiyan Liu, Chengyu Wang, et al. · European Psychiatry · 7

White matter free water and depressive symptoms in medication-free depressed adolescents: moderation by peripheral inflammation

2025 · Weicheng Li, Zerui You, et al. · Translational Psychiatry · 4

Proteomic patterns associated with ketamine response in major depressive disorders

2025 · Nan Zhou, Xiaolei Shi, et al. · Cell Biology and Toxicology · 3

Multiple peripheral inflammatory markers in adolescents with major depressive disorder treated with repeated esketamine infusions: results from a randomized controlled trial

2026 · Xiaofeng Lan, Zitao Wu, et al. · Journal of Affective Disorders · 2

Neural connectivity biotypes: predictors of clinical outcomes and improvement patterns of iTBS treatment in adolescents and young adults with depression

2025 · Weicheng Li, Yanan Yin, et al. · General Psychiatry · 2

Altered Reward Circuit Function Moderates the Relationship between Childhood Maltreatment and Depression Severity in Adolescents

2023 · Weicheng Li, Zhibo Hu, et al. · Depression and Anxiety · 2

Identifying neurophenotypes of major depressive disorder through normative model of regional homogeneity

2026 · Zhanjie Luo, Weicheng Li, et al. · Translational Psychiatry · 1

Transcriptional Signatures of Mitochondrial Metabolism Predict Esketamine-Induced rACC Structural Changes in Adolescent Major Depression

2025 · Yanling Zhou, Weicheng Li, et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1

Comparison of the Antianhedonic Effects of Repeated-dose Intravenous Ketamine in Older and Younger Adults with Major Depressive Episode

2024 · Wei Zheng, Limei Gu, et al. · Current Neuropharmacology · 1

Works count: 15

Citation count: 399

H-index: 7

I10-index: 5